Related Experiment Video
Updated: Jan 12, 2026

Isolating Mesangiogenic Progenitor Cells MPCs from Human Bone Marrow
Published on: July 15, 2016
Understanding the molecular basis of mesenchymal stem cell stemness: implications for clinical applications
Tong Ming Liu1, Wikie Tew2, Zheng Yang3,4
1Institute of Molecular and Cell Biology (IMCB), Agency for Science Technology and Research (A*STAR), Singapore, Singapore. dbsliutm@yahoo.com.
Abstract:
Human mesenchymal stem cells (MSCs) have been studied in over 1500 clinical trials to treat over 30 diseases. However, the understanding towards MSC stemness remains under studied. So far, little is known about how MSCs maintain undifferentiated state or commit to specific lineages under different microenvironmental cues. The lack of comprehensive understanding regarding MSC stemness greatly hampers the translation of research findings into successful clinical application due to unclear mechanism of action. Emerging evidence shows that a variety of genetic factors delicately regulate MSC self-renewal and differentiation. In this review, we summarize the role of transcriptional factors, cell cycle regulators, genomic stability genes, cellular quality control, epigenetic regulators, non-coding RNAs, mitochondrial function, growth factors and m6A modification in regulating the stemness of MSCs. Strategies to maintain MSC stemness during ex-vivo expansion are also discussed. This review will deepen understanding of MSC stemness for advancing clinical applications and provide insights into future directions for research aimed at improving MSC-based therapies.
Insights
Human mesenchymal stem cells (MSCs) are crucial for treating diseases, but their stemness is poorly understood. This review details factors regulating MSC stemness and strategies for ex-vivo expansion to improve therapies.
Area of Science:
- Stem Cell Biology
- Regenerative Medicine
Background:
- Human mesenchymal stem cells (MSCs) show therapeutic potential in over 1500 clinical trials for diverse diseases.
- Understanding MSC stemness (self-renewal and differentiation potential) is critical but remains underdeveloped.
- Lack of knowledge on MSC stemness mechanisms hinders clinical translation and effective application.
Purpose of the Study:
- To comprehensively review factors regulating human mesenchymal stem cell (MSC) stemness.
- To explore strategies for maintaining MSC stemness during ex-vivo expansion.
- To provide insights for advancing MSC-based clinical therapies.
Main Methods:
- Literature review summarizing current research on MSC stemness.
- Analysis of genetic and molecular factors influencing MSC self-renewal and differentiation.
- Discussion of ex-vivo expansion techniques for preserving MSC stemness.
Main Results:
- Identified key regulators of MSC stemness including transcriptional factors, epigenetic modifiers, and non-coding RNAs.
- Highlighted the roles of cell cycle, genomic stability, and mitochondrial function in maintaining stemness.
- Discussed the impact of microenvironmental cues on MSC differentiation pathways.
Conclusions:
- A deeper understanding of MSC stemness mechanisms is essential for successful clinical applications.
- Strategies for maintaining stemness during ex-vivo expansion are crucial for therapeutic efficacy.
- Further research into MSC stemness regulation will advance regenerative medicine and MSC-based therapies.
Related Concept Videos
Mesenchymal Stem Cells
Multipotency of Hematopoietic Stem Cells
Maintenance of the ES Cell State
Stem Cell Niche
Induced Pluripotent Stem Cells
Somatic...
Stem Cell Culture

